Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Brain Communications, 2023
Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosis

Zhu W., Chen C., Zhang L. et al.

Olink FocusNeurologyPatient StratificationSerum

Communications Biology, 2023
Identification of circulating proteins associated with general cognitive function among middle-aged and older adults

Tin A., Fohner A., Yang Q. et al.

Olink Target 96NeurologyPathophysiologyPlasma

BMC Medicine, 2023
Associations of ultra-processed food consumption, circulating protein biomarkers, and risk of cardiovascular disease

Li H., Wang Y., Sonestedt E. et al.

Olink Target 96CVDNutritional SciencePathophysiologyPlasma

Kidney International Reports, 2023
Proteome-Wide Changes in Blood Biomarkers During Hemodialysis

Lanktree M., Collister D., Pigyere M. et al.

Olink Target 96NephrologyHematologyPathophysiologySerum

Kidney Medicine, 2023
Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) Study

Hayward S., Chesnaye N., Hole B. et al.

Olink Target 96CVDNephrologyPatient StratificationSerum

Cell Reports Medicine, 2023
Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese

Jia X., Song E., Liu Y. et al.

Olink Target 96HepatologyPatient StratificationSerum

Clinical and Translational Allergy, 2023
Inflammatory related plasma proteins involved in acute preschool wheeze

Holmdahl I., Chakraborty S., Hoyer A. et al.

Olink Target 96Respiratory DiseasesPathophysiologyPatient StratificationPlasma

Clinical Immunology, 2023
In-depth immune profiling reveals advanced B- and T-cell differentiation to be associated with Th1-driven immune dysregulation in common variable immunodeficiency

Hultberg J., Blixt E., Göransson R. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Molecular Psychiatry, 2023
Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models

Naia L., Shimozawa M., Bereczki E. et al.

Olink Target 96 MouseNeurologyPathophysiologyCSF

Biomedicine & Pharmacotherapy, 2023
Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses

Ruiz-Ponce M., Cuesta-López L., López-Montilla M. et al.

Olink Target 96Immunological & Inflammatory DiseasesHepatologyPathophysiologyCell Culture Supernatant

Nature Communications, 2023
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis

Åkesson J., Hojjati S., Hellberg S. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasmaCSF

Journal of the American Heart Association, 2023
Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study

Shah R., Hwang S., Murthy V. et al.

Olink Target 96CVDPathophysiologyPlasma

Annals of Nutrition and Metabolism, 2023
Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial

Stenlid R., Cerenius S., Manell H. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

Nature Genetics, 2023
Rare variants with large effects provide functional insights into the pathology of migraine subtypes, with and without aura

Bjornsdottir G., Chalmer M., Stefansdottir L. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

Journal of Neurology, Neurosurgery & Psychiatry, 2023
Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy

Wieske L., Michael M., in 't Veld S. et al.

Olink Explore 3072/384NeurologyPatient StratificationSerum

Journal of Investigative Dermatology, 2023
Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial

Flora A., Jepsen R., Pham J. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum

Journal of Clinical Medicine, 2023
Cerebrospinal Fluid Proteomic Changes after Nusinersen in Patients with Spinal Muscular Atrophy

Beaudin M., Kamali T., Tang W. et al.

Olink Target 96NeurologyPatient StratificationCSF

Biomedicine & Pharmacotherapy, 2023
Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau mice

Collu R., Giunti E., Daley S. et al.

Olink Target 96CVDNeurologyPathophysiologyPlasma

Translational Psychiatry, 2023
Multivariate analyses of immune markers reveal increases in plasma EN-RAGE in first-episode psychosis patients

Korhonen L., Paul E., Wåhlén K. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma

Critical Care Explorations, 2023
Validating a Proteomic Signature of Severe COVID-19

Cosgriff C., Miano T., Mathew D. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

1889 publications